U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. Excellence in Analytical Science Group Award 2009--Present
  1. About Science & Research at FDA

Excellence in Analytical Science Group Award 2009--Present

Analytical science includes, but is not limited to, development and use of new and/or uniquely applied methods of analysis, e.g., analytical methods development, device failure analysis, drug interaction analysis, epidemiological research, predictive modeling, methods correlation and data analysis, statistical method development, etc.


Collaborators with National Institutes of Health for Accurate SARS-CoV-2 Serology Testing (CDRH)

For scientific excellence, innovation, and dedication in collaborating with National Cancer Institute on a groundbreaking program to ensure accurate serology tests for SARS-CoV-2.


Steven R. Gitterman, MD

Brendan J. O'Leary



RWE Methods Group

For extraordinary achievements in the timely development and active promotion of novel statistical methods for leveraging real-world evidence to support regulatory decision-making


Wei-Chen Chen, PhD

Heng Li, PhD

Nelson Lu, PhD

Ram Tiwari, PhD

Chenguang Wang, PhD (Professor/Collaborator)

Yunling Xu, PhD

Lilly Yue, PhD


Liposome Characterization (ORA)
Outstanding performance in the development of an analytical method for quantifying an active pharmaceutical ingredient in liposomal-based drug formulations.

Thilak Mudalige, PhD

Wenlei Jiang, PhD

Sean W. Linder, PhD

Siyam Ansar, PhD (ORISE)


The National Antimicrobial Resistance Monitoring System (NARMS) Bioinformatics Team

For developing powerful web-based tools to analyze and visualize comprehensive antibiotic resistance gene data from bacterial genomic sequences, thereby enhancing global antibiotic resistance surveillance

Heather Tate, PhD, MPH
Claudine Kabera, MPH
Chih-Hao Hsu, PhD
Gregory Tyson, MS, PhD
Shaohua Zhao, DVM, PhD,MS
Emily Crarey, MPH (C)
Daniel Tadesse, DVM, PhD
Michael Grabenstein

ZikV Reference Reagent Team

For rapid development and characterization of the CBER/FDA ZIKV RNA reference reagent as part of the FDA emergency response to the Zika virus outbreak

Maria Rios, PhD
Caren Chancey, PhD
Evgeniya Volkova, MS, MBA
Andriyan Grinev, PhD

Exact Mass Measurement Guidance Development Group

For collaborative cross-center analytical sciences research resulting in guidance for confirmation of identity of chemical residues using data produced by High-Resolution Mass Spectrometry

Timothy R. Croley, PhD
Bryan Gamble, PhD
Hiranthi Jayasuriya, PhD
Philip James Kijak, PhD
Hui Li, PhD
Sherry Turnipseed, PhD
Jon W. Wong, PhD

Shell Egg Salmonella Detection Method Development Team, CFSAN

For the development and validation of a new BAM Salmonella culture method for whole shell eggs and validation of 3 molecular methods for the detection of Salmonella in eggs.

Eric Brown, PhD
Narjol Gonzalez-Escalona, PhD
Peter Evans, PhD
Thomas Hammack, MS
Jennifer Hait
Dwayne Roberson
Eve Thau (ORISE Fellow)
Guodong Zhang, PhD
Jie Zheng, PhD

Translational Cardiac Electrophysiology Devices

For collaborative cross-center analytical sciences research that involved implementation of a novel translational science approach to answer important regulatory science questions for cardiac devices.

Daniel Caños,PhD, MPH, CDRH
Dulciana Chan, MS, CDRH
Loriano Galeotti, PhD, CDRH
Naomi Herz, MSc,
Lars Johannesen, MS, CDRH
Krystal Lansdowne, RN, CDRH
Zak Loring, MD,
Ileana Piña, MD, MPH, CDRH
William Sanders, MD, MBA, CDRH
Christopher Scully, PhD, CDRH
Kimberly Selzman, MD, M.P.H., CDRH
David Strauss, MD, PhD, CDRH
Jose Vicente, MS, CDRH
Robbert Zusterzeel, MD, CDRH

Influenza Proteomics Team

For development of mass spectrometry-based analytical methods to identify and quantify influenza vaccine components.

Michail Alterman, Ph.D., CBER
Maryna Eichelberger, Ph.D., CBER
Melkamu Getie-Kebtie, Ph.D., CBER
Ishrat Sultana, Ph. D., CBER

CBER Pandemic Influenza Preparedness Team, CBER

For the Pandemic Influenza Preparedness:  New molecular tools for better understanding of how different vaccine modalities and novel adjuvants improve protective immunity against influenza.

Hana Golding, Ph.D.
Surender Khurana, Ph.D.

Thorough QT Statistical Research Team

For significant achievement in the analytical science of the design and analysis of thorough QT studies

Yi Tsong, Ph.D.
Joanne Zhang, Ph.D.

BPA in Infant Formula Team, CFSAN

For developing a method and the analysis of bisphenol A (BPA) in infant formula to address the FDA Science Board concerns

Luke K. Lindahl-Ackerman, Ph.D.
Gregory C. Noonan, Ph.D.
John A. Roach, M.S.

PDE-5 Inhibitors and Analogs Analytical Group, ORA

For outstanding performance in characterizing and determining PDE-5 inhibitors and their analogs in illegally marketed dietary supplements.

Cheryl L. Flurer, PhD
Rick A. Fllurer, PhD
Bryan M. Gamble, PhD
Samuel R. Gratz, PhD
Merrie P. Jackson, BS
Elisa A. Nickum, BS
Valerie M. Toomey, BS











Back to Top